Table 1.
Comparison of presurgery variables and outcomes between treatment groups
| Presurgery variable | All cases (n = 281) | ORIF (n = 216) | TEA (n = 65) | p |
|---|---|---|---|---|
| Age (years), mean ± SD | 78.1 ± 7.6 | 77.9 ± 7.5 | 78.8 ± 8.0 | .42 |
| Sex female | 233 (82.9%) | 175 (81.0%) | 58 (89.2%) | .12 |
| Race | .27 | |||
| Black | 8 (2.9%) | 8 (3.7%) | 0 (0%) | |
| White | 222 (79.0%) | 168 (77.8%) | 54 (83.1%) | |
| Other/Unk | 51 (18.2%) | 40 (18.5%) | 11 (16.9%) | |
| Nonindependent functional status | 55 (19.6%) | 43 (19.9%) | 12 (18.5%) | .80 |
| Smoking | 18 (6.4%) | 15 (6.9%) | 3 (4.6%) | .77 |
| BMI (kg/m2), mean ± SD | 27.4 ± 6.5 | 27.4 ± 6.7 | 27.3 ± 5.6 | .92 |
| DM | 66 (23.5%) | 53 (24.5%) | 13 (20.0%) | .45 |
| HTN | 201 (71.5%) | 149 (69.0%) | 52 (80.0%) | .08 |
| COPD | 25 (8.9%) | 20 (9.3%) | 5 (7.7%) | .70 |
| CHF | 3 (1.1%) | 1 (0.5%) | 2 (3.1%) | .13 |
| ASA 3 or 4 | 184 (65.5%) | 136 (63.0%) | 48 (73.9%) | .11 |
| Bleeding disorder | 31 (11.0%) | 22 (10.2%) | 9 (13.9%) | .41 |
| Serum creatinine | 0.97 ± 0.74 | 0.97 ± 0.79 | 0.98 ± 0.54 | .96 |
| Hematocrit | 35.3 ± 4.4 | 35.4 ± 4.3 | 34.9 ± 4.6 | .38 |
| WBC | 8.8 ± 3.0 | 8.9 ± 3.0 | 8.4 ± 3.0 | .27 |
| Open fracture | 15 (5.3%) | 12 (5.6%) | 3 (4.6%) | .71 |
| Outcome variable | ||||
| 30-Day mortality | 2 (0.7%) | 1 (0.5%) | 1 (1.5%) | .41 |
| Transfusion | 23 (8.2%) | 16 (7.4%) | 7 (10.8%) | .39 |
| Wound event | 2 (0.7%) | 2 (0.9%) | 0 (0%) | .99 |
| Clotting event | 3 (1.1%) | 3 (1.4%) | 0 (0%) | .99 |
| Return to OR | 7 (2.5%) | 6 (2.8%) | 1 (1.5%) | .99 |
| Postsurgery LOS >7 days | 13 (4.6%) | 11 (5.1%) | 2 (3.1%) | .74 |
| Composite outcome | 44 (15.7%) | 34 (15.7%) | 10 (15.4%) | .94 |